3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
22
Breast Neoplasms
21
Neoplasms
10
Brain Neoplasms
10
Glioma
8
Head and Neck Neoplasms
7
Lymphoma
6
Colonic Neoplasms
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Lymphoma, Non-Hodgkin
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Glioblastoma
4
Carcinoma, Hepatocellular
4
Astrocytoma
4
Squamous Cell Carcinoma of Head and Neck
3
Spinal Cord Neoplasms
3
Lung Neoplasms
3
Stomach Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Oligodendroglioma
2
Neurofibromatosis 1
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Meningioma
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Interventions
Specimen Handling
2
Radiotherapy
2
Iohexol
2
Gemcitabine
2
spartalizumab
1
sodium thiosulfate
1
liposomal doxorubicin
1
X-Rays
1
Vorinostat
1
Surgical Procedures, Operative
1
Sunitinib
1
Solutions
1
Saline Solution
1
Re-Irradiation
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Probiotics
1
Platinum
1
Particle Accelerators
1
Pafolacianine
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Lidocaine
1
Ketamine
1
Injections
1
Immunotherapy, Adoptive
1
Hyperthermic Intraperitoneal Chemotherapy
1
FS 069
1
Embolization, Therapeutic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pelvic Neoplasms
×
Magnetic Resonance Imaging
×
Clear all
NCT06458725
2024-06-14
PILLAR
Jules Bordet Institute
Phase NA
Unknown
30 enrolled